Categories: Analysts

Tecsys will have a “blockbuster” second half of 2018, says Echelon

A weaker than expected quarter may give investors a chance to scoop up shares of Tecsys(TSX:TCS) at bargain prices, says Echelon Wealth Partners analyst Amr Ezzat.

On Thursday, Tecsys reported its Q1, 2018 results. The company earned $69,000 on revenue of $16.5-million a topline that was three per cent better than the same period last year.

“The first quarter of our fiscal year covers the summer months and is typically our slowest quarter,” said CEO Peter Brereton. “This year however we experienced increased sales activity in the quarter resulting in a record level of contract bookings for a first quarter. Included in the new bookings is a contract from a provincial liquor board, the fourth to choose Tecsys for its SCM (supply chain management) needs, and another from one of our largest existing customers for additional distribution centre deployment. “The continued adoption of Tecsys solutions as the standardized platform for our customers and entire sectors is a testament to both the agility and reliability of our software. Today’s rapidly evolving supply chain requires agile solutions that the old monolithic systems struggle to provide.”

Ezzat notes that the quarter came in below the street’s expectations, but says he isn’t worried about it long term. In fact, the analyst says he expects big things very shortly from the company.

“While the numbers came in below expectations during the seasonally weak first quarter, we are not too fussed and point to the extremely encouraging booking growth number of 64% y/y, implying impending strong growth,” Ezzat says. “This was furthermore confirmed with conference call commentary pointing to increased traction with Healthcare customers and continued strong Complex Distribution performance. The Company’s share price is off ~20% from its 52-week high (May 29, 2017) creating a unique buying opportunity ahead of what we foresee to be a stellar year. As reflected in our above consensus estimates, we continue to think that the stars are aligned for a blockbuster F2018 with both segments strongly contributing to top line and management keeping costs relatively flat.”

In a research update to clients today, Ezzat maintained his “Buy” rating and one-year price target of $17.50 on Tecsys, implying a return of 28.6 per cent at the time of publication.

Ezzat expects Tecsys will generate EBITDA of $9.4-million on revenue of $78.1-million in fiscal 2018. He thinks those numbers will improve to EBITDA of $11.4-million on a topline of $91.5-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: tcs
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

1 day ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

1 day ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

1 day ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago